bf/NASDAQ:CSBR_icon.jpeg

NASDAQ:CSBR

Champions Oncology, Inc.

  • Stock

USD

Last Close

4.70

17/05 20:00

Market Cap

85.03M

Beta: 0.87

Volume Today

2.73K

Avg: 10.77K

PE Ratio

−8.40

PFCF: −16.74

Apr '14
Apr '15
Apr '16
Apr '17
Apr '18
Apr '19
Apr '20
Apr '21
Apr '22
Apr '23
net income
-7.41M
-
-13.14M
77.42%
-10.45M
20.50%
-6.88M
34.10%
-1.50M
78.14%
128K
108.50%
-1.98M
1,642.97%
334K
116.91%
548K
64.07%
-5.33M
1,073.54%
depreciation and amortization
213K
-
214K
0.47%
156K
27.10%
168K
7.69%
360K
114.29%
606K
68.33%
825K
36.14%
1.18M
43.52%
1.63M
37.42%
2.25M
38.05%
deferred income tax
100K
-
65K
35%
24K
63.08%
-44K
283.33%
71K
261.36%
560K
688.73%
49K
91.25%
1.00M
-
stock based compensation
2.81M
-
3.16M
12.65%
2.60M
17.81%
2.66M
2.42%
1.00M
62.28%
636K
36.65%
600K
5.66%
598K
0.33%
912K
52.51%
864K
5.26%
change in working capital
-136K
-
424K
411.76%
1.14M
169.81%
1.15M
0.17%
-1.53M
233.68%
11K
100.72%
2.49M
22,554.55%
-4.17M
267.30%
2.34M
156.03%
4.23M
80.91%
accounts receivables
-825K
-
265K
132.12%
-282K
206.42%
-986K
249.65%
-1.60M
62.27%
-531K
66.81%
-670K
26.18%
-2.27M
238.06%
-2.82M
24.42%
1.31M
146.42%
inventory
-92K
-
-194K
110.87%
-199K
2.58%
404K
303.02%
-27K
106.68%
571K
2,214.81%
1.04M
81.61%
-1.10M
205.98%
accounts payables
-223K
-
433K
294.17%
482K
11.32%
-43K
108.92%
301K
800%
653K
116.94%
333K
49.00%
-1.25M
474.17%
974K
178.17%
2.46M
153.08%
other working capital
1.00M
-
-80K
107.97%
1.14M
1,528.75%
1.77M
54.94%
-206K
111.63%
-682K
231.07%
1.79M
362.76%
441K
75.39%
4.18M
847.85%
-3.77M
190.26%
other non cash items
1.09M
-
-390K
135.81%
30K
107.69%
44K
46.67%
491K
1,015.91%
410K
16.50%
403K
1.71%
323K
19.85%
1.07M
232.51%
952K
11.36%
net cash provided by operating activities
-3.43M
-
-9.63M
180.51%
-6.45M
33.00%
-2.84M
55.98%
-1.23M
56.83%
1.86M
251.88%
2.90M
56.02%
-1.68M
157.87%
6.50M
486.50%
3.96M
39.13%
investments in property plant and equipment
-234K
-
-119K
49.15%
-322K
170.59%
-766K
137.89%
-1.23M
60.44%
-834K
32.14%
-2.22M
166.19%
-3.28M
47.79%
-2.38M
27.34%
-2.87M
20.47%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
5K
-
3K
-
112K
-
net cash used for investing activites
-234K
-
-114K
51.28%
-322K
182.46%
-766K
137.89%
-1.23M
60.05%
-834K
31.97%
-2.22M
166.19%
-3.17M
42.75%
-2.38M
24.77%
-2.87M
20.47%
debt repayment
-12K
-
-24K
100%
-24K
0%
-25K
4.17%
-262K
948%
-35K
86.64%
-174K
397.14%
common stock issued
21K
-
11.22M
53,328.57%
44K
99.61%
4.34M
9,763.64%
30K
99.31%
6K
80%
4.46M
74,150%
1.37M
69.27%
207K
84.88%
85K
58.94%
common stock repurchased
-74K
-
dividends paid
other financing activites
2.00M
-
-18K
100.90%
8K
-
1.46M
18,137.50%
4.42M
202.95%
net cash used provided by financing activities
21K
-
13.21M
62,804.76%
2K
99.98%
4.32M
215,700%
13K
99.70%
1.20M
9,153.85%
4.42M
267.41%
1.20M
72.96%
207K
82.68%
11K
94.69%
effect of forex changes on cash
-24K
-
17K
-
net change in cash
-3.67M
-
3.47M
194.44%
-6.77M
295.38%
710K
110.48%
-2.44M
443.52%
2.23M
191.47%
5.11M
128.82%
-3.65M
171.60%
4.32M
218.19%
1.09M
74.68%
cash at beginning of period
9.56M
-
5.89M
38.39%
9.36M
58.84%
2.58M
72.37%
3.29M
27.47%
1.01M
69.47%
3.24M
221.77%
8.34M
157.71%
4.69M
43.81%
9.01M
92.17%
cash at end of period
5.89M
-
9.36M
58.84%
2.58M
72.37%
3.29M
27.47%
856K
74.02%
3.24M
278.15%
8.34M
157.71%
4.69M
43.81%
9.01M
92.17%
10.10M
12.15%
operating cash flow
-3.43M
-
-9.63M
180.51%
-6.45M
33.00%
-2.84M
55.98%
-1.23M
56.83%
1.86M
251.88%
2.90M
56.02%
-1.68M
157.87%
6.50M
486.50%
3.96M
39.13%
capital expenditure
-234K
-
-119K
49.15%
-322K
170.59%
-766K
137.89%
-1.23M
60.44%
-834K
32.14%
-2.22M
166.19%
-3.28M
47.79%
-2.38M
27.34%
-2.87M
20.47%
free cash flow
-3.67M
-
-9.75M
165.86%
-6.77M
30.52%
-3.61M
46.77%
-2.46M
31.92%
1.03M
141.87%
685K
33.37%
-4.96M
824.38%
4.11M
182.89%
1.08M
73.67%

All numbers in USD (except ratios and percentages)